ESR1 and breast cancer: The largest study to date involving 200,000 breast cancer patients was conducted by Gnerlichetal with 15,000 breast cancer patients aged <40 years at diagnosis, finding that younger women were more likely to be diagnosed with larger tumors, lymph node involvement, poorly differentiated tumors, and estrogen receptor(ER)-tumors (16).